Previous 10 | Next 10 |
MIAMI, June 02, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 2022 Jefferies Healthcare Conference taking place June 8-10, 2022 in New York City. Management will be participating in a fireside chat on Thursday, June...
OPKO Health (NASDAQ:OPK) stock gained over 4% on Tuesday after the firm disclosed that CEO and chairman Phillip Frost bought 200K shares at $2.95-$3.04 worth ~$600K. Frost Gamma Investments Trust, of which Frost is the trustee, now indirectly holds 195.9M shares in OPK. Frost Nevada Inve...
Shares of Opko Health (NASDAQ: OPK) were jumping 13.5% higher as of 12:31 p.m. ET on Tuesday. The gain came after the company announced its first-quarter results following the market close on Monday. Opko reported Q1 revenue of $329.2 million. Although this result reflected a sh...
OPKO Health (NASDAQ:OPK) stock rose ~13% on May 10 following its Q1 results a day ago and announcing plans to acquire ModeX Therapeutics. However, Piper Sandler lowered its price target on OPKO shares to $5 from $6. Q1 total revenue declined -39.62% Y/Y to $329.2M, missing analysts'...
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q1 2022 Earnings Call May 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q1 2022 Earnings Call Transcript
OPKO Health, Inc. (OPK) Q1 2022 Earnings Conference Call May 09, 2022, 16:30 ET Company Participants Yvonne Briggs - LHA Phillip Frost - Chairman & CEO Adam Logal - SVP, CFO, CAO & Treasurer Jon Cohen - SVP & Director Elias Zerhouni - Incoming President & Vice Chairman Confere...
OPKO Health press release (NASDAQ:OPK): Q1 GAAP EPS of -$0.08 misses by $0.02. Revenue of $329.2M (-39.6% Y/Y) misses by $2.25M. Cash and cash equivalents were $102.3 million as of March 31, 2022. Shares -5%. For further details see: OPKO Health GAAP EPS of -$0.08 misses by $0.02,...
MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2022. Business Highlights Business highlights for the first quarter of 2022 and subsequent weeks include the follo...
Diagnostic firm OPKO Health (NASDAQ:OPK) said on Monday it was buying privately-held ModeX Therapeutics for $300 million in common stock to expand its portfolio to include cancer and infectious disease products. ModeX, which was founded in October 2020, product portfolio ...
Dr. Elias Zerhouni, ModeX Chairman, former President of Global R&D at Sanofi and former NIH Director, named President and Vice Chairman of OPKO Dr. Gary Nabel, ModeX President and CEO, former Chief Scientific Officer at Sanofi and founder of NIH’s Vaccine Research C...
News, Short Squeeze, Breakout and More Instantly...
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common ...
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relat...
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...